✦ LIBER ✦

Impact of CYP2C19 polymorphism on residual platelet reactivity in patients with coronary heart disease during antiplatelet therapy

✍ Scribed by Koichiro Yamamoto; Seiji Hokimoto; Tadasuke Chitose; Kazunori Morita; Takamichi Ono; Koichi Kaikita; Kenichi Tsujita; Tomohide Abe; Mariko Deguchi; Haruna Miyagawa; Junji Saruwatari; Hitoshi Sumida; Seigo Sugiyama; Kazuko Nakagawa; Hisao Ogawa

Book ID: 113720291
Publisher: Elsevier
Year: 2011
Tongue: Japanese
Weight: 278 KB
Volume: 57
Category: Article
ISSN: 0914-5087
DOI: 10.1016/j.jjcc.2010.10.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

THE IMPACT OF CYP2C19 POLYMORPHISM ON CO

THE IMPACT OF CYP2C19 POLYMORPHISM ON CORONARY ARTERY SPASM IN PATIENTS WITH VASOSPASTIC ANGINA

✍ Michio Mizobe; Seiji Hokimoto; Tadasuke Chitose; Naoko Takaoka; Kenichi Tsujita; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 89 KB

The effect of elinogrel on high platelet

The effect of elinogrel on high platelet reactivity during dual antiplatelet therapy and the relation to cyp 2c19*2 genotype: first experience in patients

✍ P. A. GURBEL; K. P. BLIDEN; M. J. ANTONINO; G. STEPHENS; D. D. GRETLER; M. M. JU 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 644 KB

Residual platelet reactivity is associat

Residual platelet reactivity is associated with clinical and laboratory characteristics in patients with ischemic heart disease undergoing PCI on dual antiplatelet therapy

✍ Rossella Marcucci; Anna Maria Gori; Rita Paniccia; Cristina Giglioli; Piergiovan 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 219 KB

Pharmacodynamic effects of adjunctive ci

Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: Impact of high on-treatment platelet reactivity and diabetes mellitus status

✍ Piera Capranzano; Jose Luis Ferreiro; Masafumi Ueno; Davide Capodanno; Kodlipet 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 941 KB

Impact of Chronic Kidney Disease on Plat

Impact of Chronic Kidney Disease on Platelet Function Profiles in Diabetes Mellitus Patients With Coronary Artery Disease Taking Dual Antiplatelet Therapy

✍ Dominick J. Angiolillo; Esther Bernardo; Davide Capodanno; David Vivas; Manel Sa 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 614 KB

TCT-208: Elinogrel, A Novel Direct-actin

TCT-208: Elinogrel, A Novel Direct-acting P2Y12 Antagonist Overcomes High Platelet Reactivity in Patients on Dual Antiplatelet Therapy Independent of CYP 2C19*2 Genotype

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 161 KB